Robert J Hayes of Seer Pharma provides an analysis of the cost of maintaining a state of compliance. Since the 1930s, famous quality gurus have promoted the use of quality tools and techniques to improve product quality and reduce operating costs, such as Cost of Quality (CoQ). Although used widely in many industries, the take-up in the pharmaceutical industry is low; symptomatic of an industry that is generally slow to adopt tools, techniques and methodologies from other industry sectors.
https://international-pharma.com/wp-content/uploads/2014/03/Cost-of-quality…pdf.pdf
Current Edition
Current Edition
Subsection - CDMO
Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.
Continue readingSubsection - Injectables
Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.
Continue readingSubsection - Neurodegenerative Diseases
Exploring emerging approaches to neurodegenerative disease research and treatment.
Continue readingSubsection - Nasal & Pulmonary
Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.
Continue reading
Cost of Quality
